B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in β-catenin activated melanomas

Min Hsu, Tiphaine C. Martin, Nikki S. Vyas, Garrett Desman, Karen Mendelson, Basil Horst, Ramon E. Parsons, Julide Tok Celebi

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in β-catenin activated melanomas'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds